Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
short volume was about 640k today the shorts are playing with fire slow sto at 5.97, rsi at 26 and look how close the rs ratio and rs mom are this stock is a powder keg ready to blow. The guy who wrote the basher article today may have been telling the truth about not being short but what if his intention of the article was for him and his friends to get cheap shares? just a thought because anyone saying they will be shorting a stock this oversold has to insane.
http://stockcharts.com/h-sc/ui?s=GALE&p=D&b=5&g=0&id=p10399605688
cant even believe this sht happened today this was obviously good news and with the analysts reiterating a buy on gale this should have gone up but now the trigger is pulled so far back on gale this will really be a awesome http://stockcharts.com/h-sc/ui?s=GALE&p=D&yr=1&mn=0&dy=0&id=p35807323660rebound.
The manipulation here is unreal.
Shorts covering?
I guess no one cares about the 7$ price target or the fact that the slow sto hasn't been this low for almost a year.
It's all OVERREACTION AND HOOOBLAAAH mms shook the tree the last time today to get people to sell at the bottom
http://stockcharts.com/h-sc/ui?s=GALE&p=D&yr=1&mn=0&dy=0&id=p58230868987
212000 on the bid holy FCK LOL
Lower prices the flicking slow sto and fast are so low it's ridiculous we have to have a good upward movement from here
http://stockcharts.com/h-sc/ui?s=GALE&p=D&b=5&g=0&id=p05360540660
Wow we'll this is crappy
Big bounce tomorrow
This has had such a huge run
Doing good
Wtf....
Nice buys reversal starting today.
Awesome news Cannabics Pharmaceuticals recruits two former senior Teva Executives to its Advisory Board
Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX) announced today that the Company has made two key appointments to the Company's Advisory Board with the recent recruitment of Mr. Ika Abravanel as senior advisor in the field of operational and strategic planning, and Dr. Sigalit Ariely-Portnoy, as senior advisor in the field of regulation, validation and quality.
Both Mr. Abravanel and Dr. Ariely-Portnoy have substantial expertise, experience and knowledge relevant to the Company's mission and anticipated needs.
Mr. Ika Abravanel joined Teva Pharmaceutical Industries Ltd as its Corporate Vice President of Human Resources in 2007. During 2009, Mr. Abravanel was appointed as Teva’s Chief Integration Officer, and as such led the post-merger integration processes of Teva’s large acquisitions in recent years. In 2013 Mr. Abravanel was appointed as Group Executive Vice President of Teva Corporate in Israel and Global Community Alliances of Teva Pharmaceutical Industries Ltd. During that time he also served as Co-Chairman of the steering committee of PGT (Procter & Gamble - Teva joint venture in the field of OTC pharmaceuticals) on behalf of Teva. Mr. Abravanel holds a B.A. and an M.A. in Political Science from Haifa University and is a Graduate of the National Security College.
Dr. Sigalit Ariely-Portnoy has over 17 years’ experience in the pharmaceutical industry. During this time, she has managed pharmaceutical and chemical plants at Taro pharmaceutical industries Ltd as Operation Group Vice president and in Teva Pharmaceutical industries Ltd as Kfar-Saba OSD plant manager. Dr. Ariely-Portnoy managed Teva's largest plant worldwide (9 billion tablets per annum and more than $2B revenues). During her career, she led more than 50 inspections by the US FDA, EMEA, Israeli MOH, and others. Dr. Ariely-Portnoy spearheaded the construction of a 200,000 sq ft pharmaceutical plant, several chemical plants and bio-warehouses, as well as many significant plant expansions for manufacturers of semisolids, liquids and oral solid dosage forms. Between the years 2003-2006, Dr. Ariely-Portnoy was the president of the Israel chapter of the PDA (Parenteral Drug Association). In the last 4 and a half years, Dr. Ariely-Portnoy manages Gsap, a company which consults pharmaceutical, medical device and biotechnology companies in several major fields, including innovative product development, regulation, establishing quality systems and validation services. Dr. Ariely-Portnoy received her B.Sc., M.Sc., and D.Sc. from the Technion Institute of Technology in Haifa, Israel, in the fields of Chemical Engineering and Biomedical Engineering.
Dr. Zohar Koren, CEO of Cannabics Pharmaceuticals Inc, said, "Ika and Sigalit are both uniquely accomplished and highly qualified pharmaceutical industry veterans, who bring substantial skill sets and professional knowledge to our company at its current stage of rapid growth, scale up of manufacturing technologies, high volume market penetration and launch of clinical studies. With Ika's extensive experience in operational and strategic planning in the pharmaceutical and OTC markets, and Sigalit's long experience in designing GMP grade pharmaceutical manufacturing facilities, as well as in validation and regulatory processes, we anticipate that they will both play a prime role in our company’s advisory board and will make a significant contribution to the wide perspective of the company’s management team in the exciting and emerging field of advanced Cannabis based therapies and treatments. We are very proud and privileged to have them join us."
Nice volume today
Nice
I think we have a good day here tomorrow the fast sto and slow sto are setting up good and RSI is low
http://scharts.co/VCJh7w
Huge sells
You are your own investment philosophy? Investment Philosophy Play the volume, embrace the fear, and hold onto the truth.. FACT-Those who post constantly on these boards, have usually have constant losses, and are not very successful at trading stocks..
LOL!
Close enough lol
No idea what ur talking about
Roger is contracted by bp to try and fix problems that they have with the drilling making sure everything goes good.
All vfin does is dilute so yeah lol
I like how that guy in the forklift is looking at that guy like wtf r u doing? U don't even lift.
Lolololololol
Lol
Why so many posts?
Lower then 16 even though the 52 week low is 16 amazing.
No idea
1 for every 5 shares or something
Mm mm filthy
I pray everyday that volume of mdnt goes to zero and this goes to no bid so no one is lured into this scam anymore and people can buy good stocks and stop wasting their money.
Huge news ZAP and Jonway Auto Realigns Resource to Boost EV Production to Target Production Volume of 30,000 EVs by June 2015 to Addres...
SANTA ROSA, Calif., Aug. 13, 2014 /PRNewswire/ -- ZAP (ZAAP), an Electric Vehicle (EV) automotive company incorporated in California and headquartered in Santa Rosa, California, and its subsidiary Jonway Auto are realigning its resources to support volume production of their EV product line by putting in three parallel EV production lines in their manufacturing plant in Zhejiang Province. Two of the new EV production lines are already in full operation producing the Urbee, a city neighborhood vehicle that has drawn orders from multiple large dealerships in China, resulting in backlog over the next year of over 25,000 vehicles. The additional third new EV production line being put in place will switch from producing gasoline versions of SUV and Minivans, to supporting full electric vehicle models of the SUV and Minivan by 4th quarter of 2014. As Jonway Auto transitions from their prior focus of the gasoline vehicle business to focusing on electric vehicles as its mainstream business going forward, its current team of manufacturing engineers, technicians and managers are being retrained to expand their expertise to do mass production of EVs.
Jonway Auto is authorized by the Chinese government through Jonway Group's separate licensing entity in Hangzhou to do auto manufacturing and has the formal auto manufacturing and sales license to get the type approval for both the SUV and Minivan models for highway speed EV products. With this license and the type approvals, the electric vehicle purchases are eligible for full EV rebate incentives offered by the Central and local governments. Recent announcements confirmed that the rebate incentives will continue through to the year 2020, with additional exemptions of registration fees and sales and consumer taxes for EVs. This recent announcement also declared that 30% of the government new vehicles have to be Chinese Auto manufacturer's EVs, and when pollution indices exceed the allowed levels for the major cities, government gasoline vehicles are banned from being on the road while the pollution indices are exceeded. These economic and regulatory factors are driving government organizations to purchase full electric vehicles.
ZAP Jonway Auto's SUV can go up to 135km/hour (over 80 mph) with a range of over 200km (over 124 miles), and the minivan which has a lighter body, is engineered to reach a peak speed of over 120km/hour (75mph) and a range of over 250km (150miles) for the lithium battery versions. With the Chinese government rebates that are offered by both the central government and the local governments in major cities, the EV SUV and the EV minivan could be bought at a lower cost than the gasoline versions for the same models. These two EVs are the flagship products of ZAP and Jonway Auto. Currently Jonway Auto and ZAP's Hangzhou JV are both working on several government fleet opportunities for the EV minivan, aiming at city delivery fleets, and focusing initially on a few cities like Tianjin, Ningbo and Hangzhou. They are also working on orders for EV SUVs delivered for government organizations to replace the vehicles that their drivers use to drive around in the cities.
The minivan also comes in a lower cost lead acid model which is ideally suited for city delivery vans and has a lower range of 130 km (80 miles) with a peak speed of 100kph (62mph), and competitively priced. This is targeting international markets where there is no rebate available, but due to the competitive pricing, is well positioned for many of the SE Asian countries as well as Eastern European countries.
The Urbee was recently DOT approved for the US under NEV/LSV and is also already EU type approved for the European markets, under L6 category. The attractive lower price of the Urbee which is lead acid, will be suitable for city commuting because of the ease of parking and compactness. The range of the Urbee is over 160km (100miles) and for the L6 and DOT type approved versions, the speed is locked at 45kph (28mph) even though it is capable of peak speed of 70kph (43.5mph). This product, although focused at the lower price sector, could deliver the volume for Jonway Auto over the next year that could provide Jonway Auto's plant the production volume that they need to drive costs down for all of its other EV products, and absorb the overhead costs.